{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:16:12Z","timestamp":1770470172674,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bam University of Medical Sciences","award":["403000024"],"award-info":[{"award-number":["403000024"]}]},{"name":"Bam University of Medical Sciences","award":["403000024"],"award-info":[{"award-number":["403000024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01226-8","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:49:19Z","timestamp":1747403359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterizing substance users and risk profiles across treatment centers: insights from Iran"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-8866","authenticated-orcid":false,"given":"Saeid","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8009-470X","authenticated-orcid":false,"given":"Vahid","family":"Yazdi-Feyzabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-9277","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Mehrolhassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5808-6503","authenticated-orcid":false,"given":"Nouzar","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-3647","authenticated-orcid":false,"given":"Nadia","family":"Oroomiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"1226_CR1","unstructured":"United Nations. World Drug Report 2023. New York, https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_Exsum_fin_SP.pdf (2023)."},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11906-2","volume":"21","author":"AM Nawi","year":"2021","unstructured":"Nawi AM, Ismail R, Ibrahim F, et al. Risk and protective factors of drug abuse among adolescents: a systematic review. BMC Public Health. 2021;21:1\u201315.","journal-title":"BMC Public Health"},{"key":"1226_CR3","unstructured":"United Nations Office on Drugs and Crime. World drug report 2019. Vienna, 2019."},{"key":"1226_CR4","unstructured":"HIV\/AIDS JUNP on. Global AIDS update 2016. Geneva, https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/global-AIDS-update-2016_en.pdf (2016)."},{"key":"1226_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/070674370004501009","volume":"45","author":"A Paraherakis","year":"2000","unstructured":"Paraherakis A, Charney DA, Palacios-Boix J, et al. An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence. Can J Psychiatry. 2000;45:927\u201331.","journal-title":"Can J Psychiatry"},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15265161.2020.1861364","volume":"21","author":"BD Earp","year":"2021","unstructured":"Earp BD, Lewis J, Hart CL, et al. Racial justice requires ending the war on drugs. Am J Bioeth. 2021;21:4\u201319.","journal-title":"Am J Bioeth"},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12961-023-01050-1","volume":"21","author":"S Mirzaei","year":"2023","unstructured":"Mirzaei S, Mehrolhassani MH, Yazdi-Feyzabadi V, et al. Agenda-setting in policies related to high-risk sexual behaviours, stimulants, and alcohol abuse in Iranian adolescents. Heal Res policy Syst. 2023;21:104.","journal-title":"Heal Res policy Syst"},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/s12913-024-11256-w","volume":"24","author":"S Mirzaei","year":"2024","unstructured":"Mirzaei S, Mehrolhassani MH, Yazdi-Feyzabadi V, et al. Identifying the challenges of policy content related to high-risk sexual behaviors, stimulant drugs, and alcohol consumption in adolescents. BMC Health Serv Res. 2024;24:788.","journal-title":"BMC Health Serv Res"},{"key":"1226_CR9","doi-asserted-by":"publisher","DOI":"10.5812\/ijhrba-123294","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Oroomiei N, Nakhaee N. The first 1000 days of life and the risk of future drug consumption. Int J High Risk Behav Addict. 2022. https:\/\/doi.org\/10.5812\/ijhrba-123294.","journal-title":"Int J High Risk Behav Addict"},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12954-022-00612-w","volume":"19","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, et al. Setting the policy agenda for the treatment of substance use disorders in Iran. Harm Reduct J. 2022;19:27.","journal-title":"Harm Reduct J"},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1093\/cid\/ciad664","volume":"78","author":"K Thakarar","year":"2024","unstructured":"Thakarar K, Appa A, Abdul Mutakabbir JC, et al. Frame shift: focusing on harm reduction and shared decision making for people who use drugs hospitalized with infections. Clin Infect Dis. 2024;78:e12\u201326.","journal-title":"Clin Infect Dis"},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2215-0366(22)00435-7","volume":"10","author":"Y Rostam-Abadi","year":"2023","unstructured":"Rostam-Abadi Y, Gholami J, Jobehdar MM, et al. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. The Lancet Psychiatry. 2023;10:282\u201395.","journal-title":"The Lancet Psychiatry"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.2105\/AJPH.2022.306794","volume":"112","author":"A Farhoudian","year":"2022","unstructured":"Farhoudian A, Radfar SR. How substance use treatment services in Iran survived despite a dual catastrophic situation. Am J Public Health. 2022;112:S133\u20135.","journal-title":"Am J Public Health"},{"key":"1226_CR14","first-page":"22","volume":"22","author":"K Hajian","year":"2013","unstructured":"Hajian K, Khirkhah F, Falatoni M. Epidemiology of addiction among volunteered addicts attending in detoxification centers. J Guilan Univ Med Sci. 2013;22:22\u201330.","journal-title":"J Guilan Univ Med Sci"},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.29252\/jnkums.6.1.189","volume":"6","author":"M NorouziKhalili","year":"2014","unstructured":"NorouziKhalili M, Hojjat S, Khajedaluee M, et al. Social, economical and population characteristics of substance dependents treated in North khorasan drug rehabilitation centers. JNKUMS. 2014;6:189\u201397.","journal-title":"JNKUMS"},{"key":"1226_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13722-024-00511-4","volume":"19","author":"S Mirzaei","year":"2024","unstructured":"Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, et al. Unveiling the roadblocks: exploring substance use disorder treatment policies in Iran through a qualitative lens. Addict Sci Clin Pract. 2024;19:80.","journal-title":"Addict Sci Clin Pract"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"104325","DOI":"10.1016\/j.drugpo.2024.104325","volume":"124","author":"N Nakhaee","year":"2024","unstructured":"Nakhaee N, Karamouzian M, Sharifi H, et al. The effectiveness of court-mandated compulsory treatment in promoting abstinence among people with substance use disorders in Iran. Int J Drug Policy. 2024;124:104325.","journal-title":"Int J Drug Policy"},{"key":"1226_CR18","unstructured":"Statistical Center of Iran. Iran\u2019s Social and Cultural Status Report, https:\/\/amar.org.ir\/Portals\/0\/Articles\/gozaresh.farhangi.04.1402.pdf?ver=Z2MZ7ixVqzWnbK-iXIVsIQ%3D%3D (2024)."},{"key":"1226_CR19","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, Gossop M, Stewart D, et al. The Maudsley addiction profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93:1857\u201367.","journal-title":"Addiction"},{"key":"1226_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15171\/ijhpm.2013.24","volume":"1","author":"N Sadir","year":"2013","unstructured":"Sadir N, Shojaei M, Moadab K, et al. Outcome evaluation of therapeutic community model in Iran. Int J Heal Policy Manag. 2013;1:131\u20135.","journal-title":"Int J Heal Policy Manag"},{"key":"1226_CR21","first-page":"119","volume":"1","author":"R Afshari","year":"2010","unstructured":"Afshari R, Zare I, MoeinGh L, Taghavi. NMR. The effect of group schema therapy approach in improvement of B category personality disorders for substance dependent. Psychol Model Methods. 2010;1:119\u201334.","journal-title":"Psychol Model Methods"},{"key":"1226_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1192\/pb.30.4.134","volume":"30","author":"J Luty","year":"2006","unstructured":"Luty J, Perry V, Umoh O, et al. Validation and development of a self-report outcome measure (MAP-sc) in opiate addiction. Psychiatr Bull. 2006;30:134\u20139.","journal-title":"Psychiatr Bull"},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14659891.2023.2261055","volume":"29","author":"L RazeghianJahromi","year":"2024","unstructured":"RazeghianJahromi L, SadeghiMazidi S, Javid M, et al. Relationship between substance use-associated stigma and executive dysfunction. J Subst Use. 2024;29:881\u20135.","journal-title":"J Subst Use"},{"key":"1226_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.34172\/hpp.2023.24","volume":"13","author":"MT Kheirkhah","year":"2023","unstructured":"Kheirkhah MT, Mokarrami M, Kazemitabar M, et al. Inequalities in care for Iranian women suffering from the comorbidity of substance use and mental illness: the need for integrated treatment. Heal Promot Perspect. 2023;13:198.","journal-title":"Heal Promot Perspect"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"e15566","DOI":"10.1016\/j.heliyon.2023.e15566","volume":"9","author":"E Razaghi","year":"2023","unstructured":"Razaghi E, Farhoudian A, Pilevari A, et al. Identification of the socio-cultural barriers of drug addiction treatment in Iran. Heliyon. 2023;9:e15566.","journal-title":"Heliyon"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"1603960","DOI":"10.3389\/phrs.2021.1603960","volume":"42","author":"AI Jatau","year":"2021","unstructured":"Jatau AI, Shaaban A, Gulma KA, et al. The burden of drug abuse in Nigeria: a scoping review of epidemiological studies and drug laws. Public Health Rev. 2021;42:1603960.","journal-title":"Public Health Rev"},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3109\/10826084.2010.490971","volume":"46","author":"N Daneshmandan","year":"2011","unstructured":"Daneshmandan N, Narenjiha H, Tehrani K, et al. Initiation to the first drug use among substance-dependent persons in Iran. Subst Use Misuse. 2011;46:1124\u201341.","journal-title":"Subst Use Misuse"},{"key":"1226_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-020-00269-4","volume":"19","author":"Y-H You","year":"2020","unstructured":"You Y-H, Lu S-F, Tsai C-P, et al. Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program. Ann Gen Psychiatry. 2020;19:1\u20138.","journal-title":"Ann Gen Psychiatry"},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"e132283","DOI":"10.5812\/semj-132283","volume":"24","author":"A Moradi","year":"2023","unstructured":"Moradi A, Ranjbaran H, Moradi M, et al. The effect of harm-reducing programs in drop-in centers on the frequency of high-risk behaviors among injecting drug users in Hamadan. Shiraz E-Medical J. 2023;24:e132283.","journal-title":"Shiraz E-Medical J"},{"key":"1226_CR30","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1007\/s10461-023-04113-0","volume":"27","author":"N DesLauriers","year":"2023","unstructured":"DesLauriers N, Sambai B, Mbogo L, et al. Alcohol use among people who inject drugs living with HIV in Kenya is associated with needle sharing, more new sex partners, and lower engagement in HIV care. AIDS Behav. 2023;27:3970\u201380.","journal-title":"AIDS Behav"},{"key":"1226_CR31","doi-asserted-by":"publisher","first-page":"e21765","DOI":"10.5812\/ijhrba.21765","volume":"3","author":"S Eskandarieh","year":"2014","unstructured":"Eskandarieh S, Jafari F, Yazdani S, et al. Compulsory maintenance treatment program amongst Iranian injection drug users and its side effects. Int J high risk Behav Addict. 2014;3:e21765.","journal-title":"Int J high risk Behav Addict"},{"key":"1226_CR32","first-page":"1","volume":"119","author":"G Nikpour","year":"2018","unstructured":"Nikpour G. Drugs and drug policy in the Islamic republic of Iran. Crown Cent Middle East Stud. 2018;119:1\u20138.","journal-title":"Crown Cent Middle East Stud"},{"key":"1226_CR33","first-page":"505","volume":"10","author":"A Rahimi-Movaghar","year":"2011","unstructured":"Rahimi-Movaghar A, Khastoo G, Razzaghi E, et al. Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran (2): Outcome evaluation in two and six-month follow-up. Payesh (Health Monit). 2011;10:505\u201314.","journal-title":"Payesh (Health Monit)"},{"key":"1226_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.17795\/ijpbs1047","volume":"9","author":"H Taghizadeh","year":"2015","unstructured":"Taghizadeh H, Taghizadeh F, Fathi M, et al. Drug use and high-risk sexual behaviors of women at a drop-in center in mazandaran province, Iran, 2014. Iran J Psychiatry Behav Sci. 2015;9:49\u201355.","journal-title":"Iran J Psychiatry Behav Sci"},{"key":"1226_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/cha.2019.35","volume":"45","author":"S Mirzaei","year":"2020","unstructured":"Mirzaei S, Khosravi S, Oroomiei N. Female sex worker\u2019s children: their vulnerability in Iran. Child Aust. 2020;45:21\u20139.","journal-title":"Child Aust"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.puhe.2011.01.009","volume":"125","author":"C Lin","year":"2011","unstructured":"Lin C, Wu Z, Detels R. Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health. 2011;125:269\u201374.","journal-title":"Public Health"},{"key":"1226_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/ijerph17010119","volume":"17","author":"S Liu","year":"2019","unstructured":"Liu S, Zou X, Huang X, et al. The association between living status transitions, behavior changes and family relationship improvement among methadone maintenance treatment participants in Guangdong, China. Int J Environ Res Public Health. 2019;17:119.","journal-title":"Int J Environ Res Public Health"},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2015.12.005","volume":"28","author":"D Werb","year":"2016","unstructured":"Werb D, Kamarulzaman A, Meacham MC, et al. The effectiveness of compulsory drug treatment: a systematic review. Int J Drug Policy. 2016;28:1\u20139.","journal-title":"Int J Drug Policy"},{"key":"1226_CR39","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.1000107","author":"KA Mohammad","year":"2011","unstructured":"Mohammad KA, Hassan S, Dariush B. Crack in Iran: is it Really Cocaine? J Addict Res Ther. 2011. https:\/\/doi.org\/10.4172\/2155-6105.1000107.","journal-title":"J Addict Res Ther"},{"key":"1226_CR40","unstructured":"UNITED NATIONS OFFICE ON DRUGS AND CRIME. World Drug Report 2024. Vienna, https:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR_2024\/WDR24_Key_findings_and_conclusions.pdf (2024)."},{"key":"1226_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12024-020-00339-9","volume":"17","author":"S Paknahad","year":"2021","unstructured":"Paknahad S, Akhgari M, Ghadipasha M. An alarming rise in the prevalence of deaths with methamphetamine involved in Tehran, Iran 2011\u20132018. Forensic Sci Med Pathol. 2021;17:208\u201315.","journal-title":"Forensic Sci Med Pathol"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:49:23Z","timestamp":1747403363000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01226-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper was approved by the Ethics Committee of Bam University of Medical Sciences, Iran (IR.MUBAM.REC.1403.046). All participants provided written informed consent. Authors are responsible for correctness of the statements provided in the manuscript. Authors has consented to the submission of the manuscript to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approvals"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}